CICLOPIROX OLAMINE and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

Overview

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is the #16 most commonly reported adverse reaction for CICLOPIROX OLAMINE, manufactured by Cosette Pharmaceuticals, Inc.. There are 11 FDA adverse event reports linking CICLOPIROX OLAMINE to INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. This represents approximately 1.1% of all 975 adverse event reports for this drug.

Patients taking CICLOPIROX OLAMINE who experience inappropriate schedule of product administration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is a less commonly reported adverse event for CICLOPIROX OLAMINE, but still significant enough to appear in the safety profile.

Other Side Effects of CICLOPIROX OLAMINE

In addition to inappropriate schedule of product administration, the following adverse reactions have been reported for CICLOPIROX OLAMINE:

• DRUG INEFFECTIVE — 135 reports
• DEVICE DISLOCATION — 78 reports
• DEVICE MALFUNCTION — 78 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 36 reports
• RASH — 25 reports
• OFF LABEL USE — 23 reports
• PRURITUS — 19 reports
• CONDITION AGGRAVATED — 17 reports
• FATIGUE — 17 reports
• PAIN — 16 reports

Other Drugs Associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

The following drugs have also been linked to inappropriate schedule of product administration in FDA adverse event reports:

Does CICLOPIROX OLAMINE cause INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION has been reported as an adverse event in 11 FDA reports for CICLOPIROX OLAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION with CICLOPIROX OLAMINE?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION accounts for approximately 1.1% of all adverse event reports for CICLOPIROX OLAMINE, making it a notable side effect.

What should I do if I experience INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION while taking CICLOPIROX OLAMINE?

If you experience inappropriate schedule of product administration while taking CICLOPIROX OLAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages